Turn on the TV, every TV show the most common advertising is one of the important pharmaceutical advertising, and advertising expenditure is spending the listed pharmaceutical companies. Through the data statistics, a total of 108 companies announced the advertising expenses last year, a total of over 6876000000 yuan, of which Hayao shares to close to 900000000 yuan advertising costs ranks first, accounting for 13.09% of the total, Shanghai medicine 880000000 yuan to the advertising fee is second.
The State Administration for Industry and Commerce in 2013 February national television, newspapers published medical, pharmaceutical, health food, cosmetics and beauty service advertisements are monitoring sampling. Spot checks found 20 typical serious illegal advertising, including 8 drug ads, 2 hospitals and clinics, 1 advertising, advertising is medical equipment 5 health food advertising, 3 cosmetics advertising and 1 foot hypoglycemic advertising. On the industry suggested banning pharmaceutical advertising, but some analysts have pointed out, this calls for difficult to achieve in the short term.
An industry insiders, pharmaceutical advertising expenditure is one of the important subjects of Medicines Co sales expenses, but the current prescription is not allowed to vote in advertising, and over-the-counter drugs can advertise, most of these drugs is the treatment of cold have a fever, diarrhea and other diseases.
Cost of sales increased by 13700000000 yuan
According to the data, in 2012 the medicine plate 179 listing Corporation to achieve operating income 486300000000 yuan, of which Shanghai medicine, Kyushu, Nanjing medicine, Chinese medicine, Hayao shares, Huadong medicine, Yunnan Baiyao, Kangmei pharmaceutical, North China pharmaceutical, Intec group and other ten companies main business income of more than 10 billion yuan. However, the Medicines Co behind the high income growth is the high cost of sales of expenditure.
In 2012 the total medicine plate 179 listing Corporation sales costs 59100000000 yuan, last year the main business income accounted for 12%, these 179 companies in 2011 sales costs 45400000000 yuan, a year-on-year increase of 13700000000 yuan. The cost of sales of more than 1000000000 yuan, Shanghai pharmaceutical, Hayao shares, Hengrui medicine, Huarun three nine, Yunnan Baiyao, health yuan, Fosun Pharmaceutical, Livzon Group, Huadong Hospital, Tongrentang, Guangzhou pharmaceutical, Yibai pharmaceutical, Sanjing pharmaceutical, Tasly, Conba, Huarun Shuanghe, new pharmaceutical, Tai Chi group. Shanghai pharmaceutical sales costs 3900000000 yuan.
It is worth noting, there are 17 companies the cost of sales accounted for the main business income ratio as high as 40%, among them, Wo-hua medicine, life investment, jolly pharmaceutical, Yibai pharmaceutical, staidson, Shanghai Kai Bao, Hansen pharmaceutical companies such as cost of sales accounted for the main business income of more than 50%. Huarun three nine in 2012 the main business income of 6890000000 yuan, and the company's cost of sales is up to nearly 2200000000 yuan, year-on-year growth of 25% in 2011, while the cost of sales accounted for the main business income ratio as high as 32%.
Advertising expenses increased 1100000000 yuan
For pharmaceutical companies, one of the important expenditure of cost of sales is the advertising expenses.
According to incomplete statistics, last year the biological medicine plate published advertising company a total of 108 home, total advertising expenditures for 6876000000 yuan, according to the 2011, the value of 5746000000 yuan, a year, advertising spending up to 1100000000 yuan.
Through the data statistics, advertising expense Hayao shares in 2012 to 890000000 yuan in 2011, an increase of nearly 450000000 yuan, advertising expenditure last year's Guangzhou pharmaceutical industry is 540000000 yuan, year-on-year in 2011 increased spending of 348000000 yuan, the advertising expenses last year's Shanghai medicine for 880000000 yuan, 295000000 yuan more than in 2011 increased expenditure.
From the aggressive advertising spending, Guangzhou pharmaceutical first. Guangzhou pharmaceutical previously announced a high-profile, which in 2013 invested 2000000000 yuan to build the market cost of red canister Wang Laoji brand, advertising costs, is expected to 1000000000 yuan, equivalent to last year's total ad spending 1.8 times. The personage inside course of study expresses, and JDB for trademark right, last year, Wang Laoji increased capital spending in the advertising and promotional costs, this also led to increase in operating cost.
While some large pharmaceutical companies in advertising at the same time, also can be a number of illegal medical institutions took the opportunity to fish in troubled waters "". Recently, Tongrentang is innocent. In May 11th, Tong Ren Tang said in a statement, found that people using the "Tongrentang pharmaceutical Limited by Share Ltd" or "Beijing Tongrentang pharmaceutical Limited by Share Ltd" name, release Qihuang capsule or compound Qihuang capsule in many media advertising law. While in the illegal advertisement announcement of the State Administration for Industry and commerce, a label manufacturers as "Chinese foot Jiangtangfang Tongrentang Chinese medicinal materials in Xingan Meng limited liability company" "(foot health.)" advertising make Tongrentang list again. This thing has burst, the Related Companies immediately clear: No "Chinese foot Jiangtangfang (foot health.)" products, also has never appointed any units and individuals in the product advertising.
Source: China Network
Author: Aman Chang
The State Administration for Industry and Commerce in 2013 February national television, newspapers published medical, pharmaceutical, health food, cosmetics and beauty service advertisements are monitoring sampling. Spot checks found 20 typical serious illegal advertising, including 8 drug ads, 2 hospitals and clinics, 1 advertising, advertising is medical equipment 5 health food advertising, 3 cosmetics advertising and 1 foot hypoglycemic advertising. On the industry suggested banning pharmaceutical advertising, but some analysts have pointed out, this calls for difficult to achieve in the short term.
An industry insiders, pharmaceutical advertising expenditure is one of the important subjects of Medicines Co sales expenses, but the current prescription is not allowed to vote in advertising, and over-the-counter drugs can advertise, most of these drugs is the treatment of cold have a fever, diarrhea and other diseases.
Cost of sales increased by 13700000000 yuan
According to the data, in 2012 the medicine plate 179 listing Corporation to achieve operating income 486300000000 yuan, of which Shanghai medicine, Kyushu, Nanjing medicine, Chinese medicine, Hayao shares, Huadong medicine, Yunnan Baiyao, Kangmei pharmaceutical, North China pharmaceutical, Intec group and other ten companies main business income of more than 10 billion yuan. However, the Medicines Co behind the high income growth is the high cost of sales of expenditure.
In 2012 the total medicine plate 179 listing Corporation sales costs 59100000000 yuan, last year the main business income accounted for 12%, these 179 companies in 2011 sales costs 45400000000 yuan, a year-on-year increase of 13700000000 yuan. The cost of sales of more than 1000000000 yuan, Shanghai pharmaceutical, Hayao shares, Hengrui medicine, Huarun three nine, Yunnan Baiyao, health yuan, Fosun Pharmaceutical, Livzon Group, Huadong Hospital, Tongrentang, Guangzhou pharmaceutical, Yibai pharmaceutical, Sanjing pharmaceutical, Tasly, Conba, Huarun Shuanghe, new pharmaceutical, Tai Chi group. Shanghai pharmaceutical sales costs 3900000000 yuan.
It is worth noting, there are 17 companies the cost of sales accounted for the main business income ratio as high as 40%, among them, Wo-hua medicine, life investment, jolly pharmaceutical, Yibai pharmaceutical, staidson, Shanghai Kai Bao, Hansen pharmaceutical companies such as cost of sales accounted for the main business income of more than 50%. Huarun three nine in 2012 the main business income of 6890000000 yuan, and the company's cost of sales is up to nearly 2200000000 yuan, year-on-year growth of 25% in 2011, while the cost of sales accounted for the main business income ratio as high as 32%.
Advertising expenses increased 1100000000 yuan
For pharmaceutical companies, one of the important expenditure of cost of sales is the advertising expenses.
According to incomplete statistics, last year the biological medicine plate published advertising company a total of 108 home, total advertising expenditures for 6876000000 yuan, according to the 2011, the value of 5746000000 yuan, a year, advertising spending up to 1100000000 yuan.
Through the data statistics, advertising expense Hayao shares in 2012 to 890000000 yuan in 2011, an increase of nearly 450000000 yuan, advertising expenditure last year's Guangzhou pharmaceutical industry is 540000000 yuan, year-on-year in 2011 increased spending of 348000000 yuan, the advertising expenses last year's Shanghai medicine for 880000000 yuan, 295000000 yuan more than in 2011 increased expenditure.
From the aggressive advertising spending, Guangzhou pharmaceutical first. Guangzhou pharmaceutical previously announced a high-profile, which in 2013 invested 2000000000 yuan to build the market cost of red canister Wang Laoji brand, advertising costs, is expected to 1000000000 yuan, equivalent to last year's total ad spending 1.8 times. The personage inside course of study expresses, and JDB for trademark right, last year, Wang Laoji increased capital spending in the advertising and promotional costs, this also led to increase in operating cost.
While some large pharmaceutical companies in advertising at the same time, also can be a number of illegal medical institutions took the opportunity to fish in troubled waters "". Recently, Tongrentang is innocent. In May 11th, Tong Ren Tang said in a statement, found that people using the "Tongrentang pharmaceutical Limited by Share Ltd" or "Beijing Tongrentang pharmaceutical Limited by Share Ltd" name, release Qihuang capsule or compound Qihuang capsule in many media advertising law. While in the illegal advertisement announcement of the State Administration for Industry and commerce, a label manufacturers as "Chinese foot Jiangtangfang Tongrentang Chinese medicinal materials in Xingan Meng limited liability company" "(foot health.)" advertising make Tongrentang list again. This thing has burst, the Related Companies immediately clear: No "Chinese foot Jiangtangfang (foot health.)" products, also has never appointed any units and individuals in the product advertising.
Source: China Network
Author: Aman Chang